Giuseppe Stragliotto

Stockholm, AB 17177, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Valganciclovir Therapy Prevents Human Cytomegalovirus Reactivation in Glioblastoma Patients Undergoing Radiochemotherapy and Extends Time to Tumor Progression.

Valganciclovir Therapy Prevents Human Cytomegalovirus Reactivation in Glioblastoma Patients Undergoing Radiochemotherapy and Extends Time to Tumor Progression.

Journal: Cancers
Published: March 29, 2026

Does human cytomegalovirus provide a novel therapeutic target for patients with glioblastoma?

Does human cytomegalovirus provide a novel therapeutic target for patients with glioblastoma?

Journal: Philosophical transactions of the Royal Society of London. Series B, Biological sciences
Published: November 06, 2025

MEK inhibition in adult patients with pilocytic astrocytomas.

MEK inhibition in adult patients with pilocytic astrocytomas.

Journal: NPJ precision oncology
Published: October 11, 2025

Subtype-selective positron emission tomography imaging of poly ADP-ribose polymerase-1 binding in non-human primates, healthy volunteers, and patients with glioblastoma using [11C]AZ14193391.

Subtype-selective positron emission tomography imaging of poly ADP-ribose polymerase-1 binding in non-human primates, healthy volunteers, and patients with glioblastoma using [11C]AZ14193391.

Journal: Neuro-oncology
Published: May 08, 2024

Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer.

Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 28, 2023

Valganciclovir as Add-on to Second-Line Therapy in Patients with Recurrent Glioblastoma.

Valganciclovir as Add-on to Second-Line Therapy in Patients with Recurrent Glioblastoma.

Journal: Cancers
Published: March 04, 2022

A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma.

A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma.

Journal: Neuro-oncology advances
Published: November 12, 2021

Valganciclovir as Add-On to Standard Therapy in Secondary Glioblastoma.

Valganciclovir as Add-On to Standard Therapy in Secondary Glioblastoma.

Journal: Microorganisms
Published: September 09, 2020

Valganciclovir as Add-on to Standard Therapy in Glioblastoma Patients.

Valganciclovir as Add-on to Standard Therapy in Glioblastoma Patients.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 29, 2020

5‑Azacytidine treatment results in nuclear exclusion of DNA methyltransferase‑1, as well as reduced proliferation and invasion in human cytomegalovirus‑infected glioblastoma cells.

5‑Azacytidine treatment results in nuclear exclusion of DNA methyltransferase‑1, as well as reduced proliferation and invasion in human cytomegalovirus‑infected glioblastoma cells.

Journal: Oncology reports
Published: May 16, 2018

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.

Journal: JAMA
Published: December 21, 2017

Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial.

Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial.

Journal: Acta oncologica (Stockholm, Sweden)
Published: July 05, 2017
Showing 1-12 of 29

Last Updated: 09/26/2026